Omega Therapeutics enters agreement with Pioneering Medicines 08-B, an affiliate of Flagship Pioneering, a significant Omega shareholder.
- Agreement contemplates potential sale of all Omega assets and new financing facilities to fund a sale and wind-down process
- NOTE: Jan. 17,
Omega Therapeutics Gets Default Notice From Banc of California
To view the source of this information click
To contact the reporter on this story:
To contact the editor responsible for this story:
© 2025 Bloomberg L.P. All rights reserved. Used with permission.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.